Gene expression profile of quinacrine-cured prion-infected mouse neuronal cells

Journal of Neurochemistry

Volumn 105, Issue 1, 2008, Pages 239-250

  Fasano, Carlo ^a   Campana, Vincenza ^a   Griffiths, Beatrice ^b   Kelly, Gavin ^b   Schiavo, Giampietro ^c   Zurzolo, Chiara ^a  

^a INSTITUT PASTEUR   (France)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Differential gene expression; GT1 cells; Microarrays; Prion

Indexed keywords

CHOLESTEROL; MEPACRINE;

ANIMAL CELL; ARTICLE; BRAIN INFECTION; CELL MEMBRANE; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; GENE EXPRESSION; GENETIC CODE; GENETIC HETEROGENEITY; MEMBRANE STABILIZATION; MOLECULAR CLONING; NERVE CELL DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HYPOTHALAMUS; INFECTION; MICE; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRIONS; QUINACRINE;

ANIMALIA; SCRAPIE PRION;

EID: 41149095559     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05140.x     Document Type: Article

References (61)

1. Baker C. A. Manuelidis L. (2003) Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl Acad. Sci. USA 100, 675 679.
2. Bate C., Reid S. Williams A. (2004) Phospholipase A2 inhibitors or platelet-activating factor antagonists prevent prion replication. J. Biol. Chem. 279, 36405 36411.
3. Bogdanov M. Dowhan W. (1999) Lipid-assisted protein folding. J. Biol. Chem. 274, 36827 36830.
4. Booth S., Bowman C., Baumgartner R., Sorensen G., Robertson C., Coulthart M., Phillipson C. Somorjai R. L. (2004a) Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection. J. Gen. Virol. 85, 3459 3471.
5. Booth S., Bowman C., Baumgartner R., Dolenko B., Sorensen G., Robertson C., Coulthart M., Phillipson C. Somorjai R. (2004b) Molecular classification of scrapie strains in mice using gene expression profiling. Biochem. Biophys. Res. Commun. 325, 1339 1345.
6. Bosque P. J. Prusiner S. B. (2000) Cultured cell sublines highly susceptible to prion infection. J. Virol. 74, 4377 4386.
7. Campana V., Sarnataro D. Zurzolo C. (2005) The highways and byways of prion protein trafficking. Trends Cell Biol. 15, 102 111.
8. Campana V., Sarnataro D., Fasano C., Casanova P., Paladino S. Zurzolo C. (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J. Cell Sci. 119, 433 442.
9. Castilla J., Saa P., Hetz C. Soto C. (2005) In vitro generation of infectious scrapie prions. Cell 121, 195 206.
10. Coitinho A. S., Freitas A. R., Lopes M. H. et al. (2006) The interaction between prion protein and laminin modulates memory consolidation. Eur. J. Neurosci. 24, 3255 3264.
11. Dandoy-Dron F., Guillo F., Benboudjema L., Deslys J. P., Lasmezas C., Dormont D., Tovey M. G. Dron M. (1998) Gene expression in scrapie. Cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts. J. Biol. Chem. 273, 7691 7697.
12. Doh-ura K., Tateishi J., Sasaki H., Kitamoto T. Sakaki Y. (1989) Pro-leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Straussler syndrome. Biochem. Biophys. Res. Commun. 163, 974 979.
13. Doh-Ura K., Iwaki T. Caughey B. (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74, 4894 4897.
14. Ehehalt R., Keller P., Haass C., Thiele C. Simons K. (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113 123.
15. Fasano C., Campana V. Zurzolo C. (2006) Prions: protein only or something more? Overview of potential prion cofactors J. Mol. Neurosci. 29, 195 214.
16. Feraudet C., Morel N., Simon S., Volland H., Frobert Y., Creminon C., Vilette D., Lehmann S. Grassi J. (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280, 11247 11258.
17. Gauczynski S., Peyrin J. M., Haik S. et al. (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863 5875.
18. Gauczynski S., Nikles D., El-Gogo S., Papy-Garcia D., Rey C., Alban S., Barritault D., Lasmezas C. I. Weiss S. (2006) The 37-kDa/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes. J. Infect. Dis. 194, 702 709.
19. Giese A. Kretzschmar H. A. (2001) Prion-induced neuronal damage - the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr. Top. Microbiol. Immunol. 253, 203 217.
20. Giese A., Brown D. R., Groschup M. H., Feldmann C., Haist I. Kretzschmar H. A. (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8, 449 457.
21. Goris A., Sawcer S., Vandenbroeck K., Carton H., Billiau A., Setakis E., Compston A. Dubois B. (2003) New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. J. Neuroimmunol. 143, 65 69.
22. Graner E., Mercadante A. F., Zanata S. M., Martins V. R., Jay D. G. Brentani R. R. (2000a) Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett. 482, 257 260.
23. Graner E., Mercadante A. F., Zanata S. M. et al. (2000b) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76, 85 92.
24. Greenwood A. D., Horsch M., Stengel A. et al. (2005) Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J. Mol. Biol. 349, 487 500.
25. Horonchik L., Tzaban S., Ben-Zaken O., Yedidia Y., Rouvinski A., Papy-Garcia D., Barritault D., Vlodavsky I. Taraboulos A. (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J. Biol. Chem. 280, 17062 17067.
26. Hur K., Kim J. I., Choi S. I., Choi E. K., Carp R. I. Kim Y. S. (2002) The pathogenic mechanisms of prion diseases. Mech. Ageing Dev. 123, 1637 1647.
27. Ju W. K., Park K. J., Choi E. K., Kim J., Carp R. I., Wisniewski H. M. Kim Y. S. (1998) Expression of inducible nitric oxide synthase in the brains of scrapie-infected mice. J. Neurovirol. 4, 445 450.
28. Kargul G. J., Dudekula D. B., Qian Y., Lim M. K., Jaradat S. A., Tanaka T. S., Carter M. G. Ko M. S. (2001) Verification and initial annotation of the NIA mouse 15K cDNA clone set. Nat. Genet. 28, 17 18.
29. Kempster S., Collins M. E., Aronow B. J., Simmons M., Green R. B. Edington N. (2004) Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15, 1735 1738.
30. Klepper J. (2004) Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome. Curr. Opin. Neurol. 17, 193 196.
31. Klingenstein R., Lober S., Kujala P., Godsave S., Leliveld S. R., Gmeiner P., Peters P. J. Korth C. (2006) Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J. Neurochem. 98, 748 759.
32. Laszlo L., Lowe J., Self T. et al. (1992) Lysosomes as key organelles in the pathogenesis of prion encephalopathies. J. Pathol. 166, 333 341.
33. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmezas C. I. Weiss S. (2003) The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep 4, 290 295.
34. Lin Y. H., Park Z. Y., Lin D., Brahmbhatt A. A., Rio M. C., Yates J. R. 3rd. Klemke R. L. (2004) Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J. Cell Biol. 165, 421 432.
35. Lindegren H., Ostlund P., Gyllberg H. Bedecs K. (2003) Loss of lipopolysaccharide-induced nitric oxide production and inducible nitric oxide synthase expression in scrapie-infected N2a cells. J. Neurosci. Res. 71, 291 299.
36. Livak K. J. Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402 408.
37. Luhr K. M., Nordstrom E. K., Low P. Kristensson K. (2004) Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells. Neuroreport 15, 1663 1667.
38. Martinez T. Pascual A. (2007) Gene expression profile in beta-amyloid-treated SH-SY5Y neuroblastoma cells. Brain Res. Bull. 72, 225 231.
39. Morel E., Andrieu T., Casagrande F., Gauczynski S., Weiss S., Grassi J., Rousset M., Dormont D. Chambaz J. (2005) Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am. J. Pathol. 167, 1033 1042.
40. Nakanishi H. (2003) Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res. Rev. 2, 367 381.
41. Nishida N., Harris D. A., Vilette D., Laude H., Frobert Y., Grassi J., Casanova D., Milhavet O. Lehmann S. (2000) Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74, 320 325.
42. Prusiner S. B. (1998) Prions. Proc. Natl Acad. Sci. USA 95, 13363 13383.
43. Rieger R., Edenhofer F., Lasmezas C. I. Weiss S. (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat. Med. 3, 1383 1388.
44. Riemer C., Neidhold S., Burwinkel M., Schwarz A., Schultz J., Kratzschmar J., Monning U. Baier M. (2004) Gene expression profiling of scrapie-infected brain tissue. Biochem. Biophys. Res. Commun. 323, 556 564.
45. Rubinsztein D. C., DiFiglia M., Heintz N., Nixon R. A., Qin Z. H., Ravikumar B., Stefanis L. Tolkovsky A. (2005) Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1, 11 22.
46. Saborio G. P., Permanne B. Soto C. (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810 813.
47. Sanders C. R. Nagy J. K. (2000) Misfolding of membrane proteins in health and disease: the lady or the tiger? Curr. Opin. Struct. Biol. 10, 438 442.
48. Sarnataro D., Campana V., Paladino S., Stornaiuolo M., Nitsch L. Zurzolo C. (2004) PrPC Association with Lipid Rafts in the Early Secretory Pathway Stabilizes Its Cellular Conformation. Mol. Biol. Cell 15, 4031 4042.
49. Shin T., Kang B., Tanuma N., Matsumoto Y., Wie M., Ahn M. Kang J. (2001) Intrathecal administration of endothelin-1 receptor antagonist ameliorates autoimmune encephalomyelitis in Lewis rats. Neuroreport 12, 1465 1468.
50. Shin K., Straight S. Margolis B. (2005) PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J. Cell Biol. 168, 705 711.
51. Shmakov A. N., Bode J., Kilshaw P. J. Ghosh S. (2000) Diverse patterns of expression of the 67-kD laminin receptor in human small intestinal mucosa: potential binding sites for prion proteins? J. Pathol. 191, 318 322.
52. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G. Simons K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460 6464.
53. Speciale L., Sarasella M., Ruzzante S., Caputo D., Mancuso R., Calvo M. G., Guerini F. R. Ferrante P. (2000) Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurovirol. 6 (Suppl. 2 S62 S66.
54. Staniforth R. A., Giannini S., Higgins L. D., Conroy M. J., Hounslow A. M., Jerala R., Craven C. J. Waltho J. P. (2001) Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J. 20, 4774 4781.
55. Taraboulos A., Scott M., Semenov A., Avrahami D., Laszlo L., Prusiner S. B. Avraham D. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129, 121 132.
56. Uchiyama Y. (2001) Autophagic cell death and its execution by lysosomal cathepsins. Arch. Histol. Cytol. 64, 233 246.
57. Vana K., Zuber C., Nikles D. Weiss S. (2007) Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell. Mol. Neurobiol. 27, 107 128.
58. Walmsley A. R., Zeng F. Hooper N. M. (2003) The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant. J. Biol. Chem. 278, 37241 37248.
59. Wollmer M. A., Streffer J. R., Lutjohann D. et al. (2003) ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol. Aging 24, 421 426.
60. Xiang W., Windl O., Wunsch G., Dugas M., Kohlmann A., Dierkes N., Westner I. M. Kretzschmar H. A. (2004) Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology. J. Virol. 78, 11051 11060.
61. Zhang Y., Spiess E., Groschup M. H. Burkle A. (2003) Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J. Gen. Virol. 84, 2279 2283.